Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs
Authors:
- 16 August 2018
- journal article
- research article
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 16 (4) , 622-629
Abstract
Canine T cell lymphoma has previously been found to be a poor prognostic indicator compared with its B cell counterpart. The cyclophosphamide, doxorubicin, vincristine, and prednisolone protocol is widely accepted as a first line treatment for canine lymphoma. There have been several studies investigating alternative protocols for T cell lymphoma. This study investigated the use of a modified lomustine, vincristine, procarbazine and prednisolone protocol as a first line treatment in 35 dogs with T Cell lymphoma. Median progression free survival (PFS) time for all 35 dogs was 431 days with a 6‐month, 1‐year, 2‐year, and 3‐year PFS of 69%, 54%, 29%, and 12%. Median survival time (MST) was 507 days. Twenty‐nine dogs attained a complete response and had a median PFS time of 509 days. Thirty dogs experienced adverse events during the protocol, with 73% of these being grade 1 or 2. This protocol has shown increased median PFS time and MST compared with previous studies and suggests its use as a first line chemotherapy protocol against canine T cell lymphoma.Keywords
This publication has 27 references indexed in Scilit:
- Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003–2009)Journal of the American Veterinary Medical Association, 2011
- CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07)Australian Veterinary Journal, 2011
- CHOP chemotherapy for the treatment of canine multicentric T‐cell lymphomaVeterinary and Comparative Oncology, 2011
- Comparison between l-CHOP and an l-CHOP protocol with interposed treatments of CCNU and MOPP (l-CHOP-CCNU-MOPP) for lymphoma in dogsVeterinary and Comparative Oncology, 2010
- Response rate after administration of a single dose of doxorubicin in dogs with B-cell or T-cell lymphoma: 41 cases (2006–2008)Journal of the American Veterinary Medical Association, 2010
- Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 casesVeterinary and Comparative Oncology, 2010
- Asparaginase and MOPP Treatment of Dogs with LymphomaJournal of Veterinary Internal Medicine, 2009
- Efficacy and toxicity of BOPP and LOPP chemotherapy for the treatment of relapsed canine lymphoma*Veterinary and Comparative Oncology, 2006
- Evaluation of a 6-Month Chemotherapy Protocol with No Maintenance Therapy for Dogs with LymphomaJournal of Veterinary Internal Medicine, 2002
- Evaluation of a High-Dose Chemotherapy Protocol with No Maintenance Therapy for Dogs with LymphomaJournal of Veterinary Internal Medicine, 2000